21 In a randomized placebo-controlled trial in 31 people with rosacea being treated with minocycline (Minocin), the addition of 320 mg GLA twice daily for eight weeks resulted in greater improvement in skin hydration, higher likelihood of achieving treatment success, and better patient satisfaction
Current Clinical Evidence for GLP-1 Use in Prader-Willi Syndrome Published case series and small observational studies suggest that semaglutide and tirzepatide may reduce appetite and promote weight loss in PWS patients
doi: 10.1211/002235702649
Lifestyle Foundations First While supplementing with 1500 mg of glutathione can support your antioxidant defences, it is not a substitute for a healthy lifestyle
According to a meta-analysis evaluating 453 trials and 21 antidiabetic treatments, oral semaglutide reduces all-cause mortality and cardiovascular death, with the lowest odds ratios (ORs) among the treatments evaluated (empagliflozin, liraglutide, extended-release exenatide, dapagliflozin, dulaglutide, lixisenatide, canagliflozin, pioglitazone, DPP-4 inhibitors, subcutaneous semaglutide, sulphonylureas) [56]
Companies are competing to offer treatments that provide: Strong weight-loss results Favorable safety profiles Convenient dosing Broad patient appeal Industry Impact Pharmaceutical Companies: The development intensifies competition within the rapidly expanding obesity-treatment market